Skip to main content
    C

    Core Scientific, Inc. Common Stock (CORZ)

    Official site

    TECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NASDAQ

    $13.58
    -0.94 (-6.47%)

    Market Cap: $4.68B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Core Scientific, Inc. Common Stock (CORZ) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Core Scientific, Inc. Common Stock reported revenue of $319.02M for the fiscal year ended Sep 30, 2025, down 37.5% from the year before. That year, net income was -$288.62M with a net margin of -90.5%, operating cash flow was $278.25M and free cash flow was -$450.75M. The quarter ended Sep 30, 2026 had revenue of $232.87M and net income of $1.18B.

    Revenue and Margins

    The operating margin was -70.4% in the fiscal year ended Sep 2025, the lowest of the 7 years shown. Over the 6 years to Sep 2025, revenue grew from $59.52M, a compound annual rate of 32.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025$319.02M-37.5%11.9%-70.4%-90.5%
    Sep 2024$510.67M+1.6%23.7%-3.8%-257.5%
    Sep 2023$502.40M-21.5%24.6%1.8%-49.1%
    Sep 2022$640.31M+17.6%1.3%-38.2%-335.2%
    Sep 2021$544.48M+802.7%43.9%30.6%8.7%
    Sep 2020$60.32M+1.3%15.6%-10.5%-20.2%
    Sep 2019$59.52MN/A17.7%-19.6%-20.0%
    Annual, fiscal years ended Sep 2019 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019
    Revenue$319.02M$510.67M$502.40M$640.31M$544.48M$60.32M$59.52M
    Cost of revenue$281.12M$389.60M$378.94M$631.91M$305.62M$50.93M$49.00M
    Gross profit$37.90M$121.07M$123.46M$8.40M$238.86M$9.39M$10.53M
    Research and development$0$11.83M$7.18M$26.96M$7.67M$5.27M$5.48M
    Operating income-$224.55M-$19.20M$8.96M-$244.57M$166.64M-$6.33M-$11.69M
    Net income-$288.62M-$1.32B-$246.49M-$2.15B$47.31M-$12.21M-$11.92M
    EBITDA-$207.85MN/AN/AN/AN/A$1.63M-$5.57M
    Fiscal years ended Sep 2019 to Sep 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$232.87M$164.20M$115.24M$79.76M$81.10M$78.63M$79.53M$94.92M$95.35M$141.10M$179.29M$141.93M
    Gross profit$123.27M$70.04M$29.75M$20.88M$3.78M$5.03M$8.21M$4.76M-$156.00K$38.82M$77.65M$39.30M
    Operating income$72.35M-$72.13M-$23.74M$13.00M-$65.45M-$26.28M-$47.03M-$39.78M-$41.22M$6.58M$55.23M$3.93M
    Net income$1.18B-$1.16B-$347.19M$214.15M-$146.66M-$936.80M$576.25M-$265.54M-$455.26M-$804.90M$210.69M-$195.69M
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, long-term debt of $1.06B exceeded cash and equivalents by $748.95M. Shareholder equity was negative, at -$962.74M, as total liabilities of $3.31B exceeded total assets of $2.35B.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019
    Total assets$2.35B$1.60B$712.16M$807.69M$2.44B$225.58M$162.01M
    Current assets$895.54M$903.96M$97.02M$85.10M$756.56M$70.92M$11.05M
    Cash and equivalents$311.38M$836.20M$50.41M$15.88M$117.87M$8.67M$6.66M
    Total liabilities$3.31B$2.42B$1.31B$1.22B$1.10B$91.88M$26.16M
    Short-term debtN/A$27.93M$144.21MN/A$104.45M$18.16M$2.22M
    Long-term debt$1.06B$1.07B$684.08MN/A$652.21M$19.86M$2.09M
    Shareholder equity-$962.74M-$820.18M-$596.94M-$409.35M$1.34B$133.70M$135.85M
    Fiscal years ended Sep 2019 to Sep 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$5.94B$5.26B$3.07B$2.35B$2.30B$1.98B$1.63B$1.60B$921.85M$761.46M$813.97M$712.16M
    Total liabilities$7.03B$7.68B$4.38B$3.31B$3.42B$3.04B$1.81B$2.42B$1.65B$1.85B$1.13B$1.31B
    Cash and equivalents$803.94M$1.77B$1.01B$311.38M$453.44M$581.35M$697.94M$836.20M$253.02M$96.12M$98.13M$50.41M
    Shareholder equity-$1.09B-$2.42B-$1.31B-$962.74M-$1.13B-$1.06B-$181.51M-$820.18M-$729.39M-$1.08B-$318.51M-$596.94M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Sep 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019
    Operating cash flow$278.25M$42.90M$65.11M$205.19M-$56.73M-$23.77M-$832.00K
    Capital expenditures$729.00M$94.96M$16.16M$601.66M$59.27M$1.57M$37.41M
    Free cash flow-$450.75M-$52.06M$48.95M-$396.47M-$116.01M-$25.33M-$38.24M
    Investing cash flow-$740.75M-$95.19M-$3.00MN/A-$423.84M-$15.14M-$37.36M
    Financing cash flow-$63.10M$819.57M-$44.65M$306.15M$603.53M$40.72M$28.69M
    Fiscal years ended Sep 2019 to Sep 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$65.29M-$18.93M$249.88M$153.07M$131.78M$34.00M-$45.04M$13.80M$5.71M$1.20M$22.17M$21.70M
    Capital expenditures$540.74M$565.02M$389.23M$274.81M$254.62M$121.28M$84.02M$28.76M$31.05M$3.13M$31.89M$11.64M
    Free cash flow-$475.44M-$583.95M-$139.35M-$121.74M-$122.84M-$87.28M-$129.06M-$14.95M-$25.34M-$1.93M-$9.72M$10.06M
    Last 12 quarters

    Frequently Asked Questions About CORZ

    What is Core Scientific, Inc. Common Stock's annual revenue?

    Core Scientific, Inc. Common Stock reported revenue of $319.02M for the fiscal year ended Sep 30, 2025.

    How fast is Core Scientific, Inc. Common Stock's revenue growing?

    Revenue was down 37.5% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -20.7%.

    Is Core Scientific, Inc. Common Stock profitable?

    No. Core Scientific, Inc. Common Stock reported net income of -$288.62M for the fiscal year ended Sep 30, 2025, with a net margin of -90.5%.

    How much free cash flow does CORZ generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of $278.25M minus capital expenditures of $729.00M produced free cash flow of -$450.75M.

    How much debt does Core Scientific, Inc. Common Stock have?

    The balance sheet dated Sep 30, 2025 reported long-term debt of $1.06B and cash and equivalents of $311.38M.